Bank of America
BBOT

Bank of America’s BridgeBio Oncology BBOT Stock Holding History

Bank of America’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,990
Closed -$50K – 6971
2025
Q4 		$50K Buy
3,990
+2,661
+200% +$32.2K ﹤0.01% 5843
2025
Q3 		$15.4K Buy
+1,329
New +$13.8K ﹤0.01% 7121

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America's BBOT Position: Q1 2026 in Review

Bank of America sold out of BridgeBio Oncology (BBOT) in Q1 2026, closing a stake of 3,990 shares — an estimated $50K sold.

Bank of America first reported a position in BBOT in Q3 2025 and held it in 2 quarters. The position peaked at $50K in Q4 2025. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • Bank of America reported no remaining BridgeBio Oncology position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,990 BridgeBio Oncology shares in Q1 2026, an estimated $50K.
  • Bank of America first reported a position in BridgeBio Oncology in Q3 2025 and held it in 2 quarters.
  • Bank of America's BridgeBio Oncology position peaked at $50K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.